Skip to main content
OpenTrials

Clinical trial condition

Ovarian Neoplasms

Explore clinical trials studying Ovarian Neoplasms. Study availability and eligibility vary by location and protocol.

2,293 public trials 504 recruiting studies
Refine in advanced search Browse all conditions

Ovarian Neoplasms trial results

Completed

Veliparib in Treating Patients With Persistent or Recurrent Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancer

NCT01540565

Conditions
Adnexal Diseases, BRCA1 Mutation Carrier, BRCA2 Mutation Carrier, +20 more
Locations
  • Saint Joseph's Hospital and Medical Center Phoenix, Arizona, United States
  • John Muir Medical Center-Concord Campus Concord, California, United States
  • UC San Diego Moores Cancer Center La Jolla, California, United States
  • Gynecologic Oncology Associates-Newport Beach Newport Beach, California, United States
View all 153 locations
View Trial Details
Completed

Pegylated Liposomal Doxorubicin Hydrochloride, Carboplatin, Veliparib, and Bevacizumab in Treating Patients With Recurrent Ovarian Cancer, Primary Peritoneal Cancer, or Fallopian Tube Cancer

NCT01459380

Conditions
Adnexal Diseases, Endocrine Gland Neoplasms, Endocrine System Diseases, +22 more
Locations
  • University of Colorado Cancer Center - Anschutz Cancer Pavilion Aurora, Colorado, United States
  • Augusta University Medical Center Augusta, Georgia, United States
  • University of Chicago Comprehensive Cancer Center Chicago, Illinois, United States
  • University of Iowa/Holden Comprehensive Cancer Center Iowa City, Iowa, United States
View all 13 locations
View Trial Details
Completed

LEE011 for Patients With CDK4/6 Pathway Activated Tumors (SIGNATURE)

NCT02187783

Conditions
Adenoma, Adnexal Diseases, Breast Diseases, +31 more
Locations
  • University of Alabama at Birmingham Birmingham, Alabama, United States
  • Alaska Clinical Research Anchorage, Alaska, United States
  • Arizona Oncology Associates Dept. Of Onc. Phoenix, Arizona, United States
  • University of Arkansas/ Arkansas Cancer Research Center UA Medical Sciences Little Rock, Arkansas, United States
View all 61 locations
View Trial Details
Completed

CT Antigen TCR-redirected T Cells for Ovarian Cancer.

NCT01567891

Conditions
Adnexal Diseases, Endocrine Gland Neoplasms, Endocrine System Diseases, +17 more
Locations
  • City of Hope National Medical Center Duarte, California, United States
  • Stanford Cancer Institute Stanford, California, United States
  • University of Miami, Sylvester Comprehensive Cancer Center Miami, Florida, United States
  • Roswell Park Cancer Institute Buffalo, New York, United States
View Trial Details

Related conditions